ODT’s Most Read Articles in January

Last months popular news items included FDA warnings, new product and system launches as well as company acquisitions.
 
The FDA issued two warning letters against Equinoxe and Synovo products. Equinoxe’s shoulder implant system experienced possible wear and tear issues from ineffective packaging. The FDA warned against Synovo Total Hip Resurfacing Systems manufactured after 2019.
 
Smith+Nephew was popular this month for acquiring CartiHeal. The company also released promising results for its REGENETEN Bioinductive Implant. 
 
The deal for LimaCorporate was also completed by Enovis. 
 
Another popular company was Paragon 28 for launching its Grappler knotless anchor system and Bridgeline Tape. Paragon 28 also began limited market launch and announced the first surgical cases for its Bun-Yo-Matic Lapidus clamp system.
 
1. FDA Warns of Possible Equinoxe Shoulder Implant Wear and Tear

2. Enovis Closes €800M Deal for LimaCorporate

3. Stryker Marks First Surgeries with Blueprint Mixed-Reality Shoulder Surgery Guidance

4. Julie Andrews Joins Orthofix as Chief Financial Officer

5. Smith+Nephew’s REGENETEN Implant Reduces Full-Thickness Rotator Cuff Re-Tear Rates

6. Smith+Nephew Acquires CartiHeal

7. Paragon 28 Rolls Out Grappler Knotless Anchor System & Bridgeline Tape

8. FDA: Do Not Use Synovo Total Hip Resurfacing System

9. Nano Arthroscopy Poised to Revolutionize Orthopedic Market

10. First Cases, Soft Launch for Paragon 28’s Bun-Yo-Matic Clamp & Cut Guide